Form 10-Q/A - Quarterly report [Sections 13 or 15(d)]: [Amend]
SEC Accession No. 0001096906-23-002008
Filing Date
2023-10-17
Accepted
2023-10-17 17:07:55
Documents
54
Period of Report
2022-06-30

Document Format Files

Seq Description Document Type Size
1 MYCOTOPIA THERAPIES, INC. - FORM 10-Q/A SEC FILING tpia-20220630.htm   iXBRL 10-Q/A 539030
  Complete submission text file 0001096906-23-002008.txt   2968918

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT tpia-20220630_cal.xml EX-101.CAL 19128
3 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT tpia-20220630_def.xml EX-101.DEF 69289
4 XBRL TAXONOMY EXTENSION LABELS LINKBASE DOCUMENT tpia-20220630_lab.xml EX-101.LAB 160532
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT tpia-20220630_pre.xml EX-101.PRE 144390
6 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT tpia-20220630.xsd EX-101.SCH 32441
48 EXTRACTED XBRL INSTANCE DOCUMENT tpia-20220630_htm.xml XML 406726
Mailing Address 480 22ND STREET HEYBURN ID 83336
Business Address 480 22ND STREET HEYBURN ID 83336 208-677-2020
Mycotopia Therapies, Inc. (Filer) CIK: 0001763329 (see all company filings)

EIN.: 870645794 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 10-Q/A | Act: 34 | File No.: 000-56022 | Film No.: 231330298
SIC: 2833 Medicinal Chemicals & Botanical Products